SW48

SW48

收藏
  • 询价
  • 2025年12月31日
    avatar
    14金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 技术资料
    • 相关疾病

      大肠癌

    • ATCC Number

      CCL-231™

    • 年限

      Dukes' type C, grade IV

    • 库存

      大量

    • 细胞形态

      上皮样

    • 运输方式

      冻存运输

    • 器官来源

      结肠

    • 生长状态

      贴壁生长

    • 物种来源

    • 是否是肿瘤细胞

      1

    Designations: SW48 [SW-48]
    Depositors:  A Leibovitz
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: adherent
    Organism: Homo sapiens
    Morphology: epithelial

    Source: Organ: colon
    Tumor Stage: Dukes' type C, grade IV
    Disease: colorectal adenocarcinoma
    Cellular Products: carcinoembryonic antigen (CEA) 0.6 ng/10 exp6 cells/10 days; keratin
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Applications: transfection host
    Tumorigenic: Yes
    Antigen Expression: HLA A32, A33, B27, B35; blood type AB; Rh+
    DNA Profile (STR): Amelogenin: X
    CSF1PO: 9, 10
    D13S317: 11, 12
    D16S539: 11, 13
    D5S818: 10, 14
    D7S820: 9, 10
    THO1: 6, 9.3
    TPOX: 8
    vWA: 18, 20, 21
    Isoenzymes: ES-D, 1
    G6PD, B
    PEP-D, 1
    PGD, A
    PGM1, 1
    PGM3, 1-2
    Age: 82 years
    Gender: female
    Ethnicity: Caucasian
    Comments: CSAp negative (CSAp-).
    The cells are positive for keratin by immunoperoxidase staining.
    Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Leibovitz's L-15 Medium, Catalog No. 30-2008. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
    Atmosphere: air, 100%
    Temperature: 37.0°C
    Subculturing: Protocol:
    1. Culture never becomes 100% confluent. Remove and discard culture medium.
    2. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution to remove all traces of serum that contains trypsin inhibitor.
    3. Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
      Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37�C to facilitate dispersal.
    4. Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.
    5. To remove trypsin-EDTA solution, transfer cell suspension to a centrifuge tube and spin at approximately 125 xg for 5 to10 minutes.Discard supernatant and resuspend cells in fresh growth medium. Add appropriate aliquots of cell suspension to new culture vessels..
    6. Incubate cultures at 37�C.

    Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:6 is recommended
    Medium Renewal: 1 to 2 times per week
    Preservation: Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
    Storage temperature: liquid nitrogen vapor phase
    Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2008
    recommended serum:ATCC 30-2020
    References: 22140: . . In Vitro 8: 443, 1973.
    22147: Chen TR, et al. Intercellular karyotypic similarity in near-diploid cell lines of human tumor origins. Cancer Genet. Cytogenet. 10: 351-362, 1983. PubMed: 6652615
    22260: Chen TR, et al. Karyotype consistency in human colorectal carcinoma cell lines established in vitro. Cancer Genet. Cytogenet. 6: 93-117, 1982. PubMed: 7104989
    22539: Fogh J, et al. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59: 221-226, 1977. PubMed: 327080
    23025: Leibovitz A, et al. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36: 4562-4569, 1976. PubMed: 1000501
    25093: Santoro IM, Groden J. Alternative splicing of the APC gene and its association with terminal differentiation. Cancer Res. 57: 488-494, 1997. PubMed: 9012479
    32265: Tsao H, et al. Novel mutations in the p16/CDKN2A binding region of the Cyclin-dependent Kinase-4 gene. Cancer Res. 58: 109-113, 1998. PubMed: 9426066

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1620
    博辉生物科技(广州)有限公司
    2025年11月20日询价
    ¥1980
    上海酶研生物科技有限公司
    2025年07月11日询价
    ¥800
    上海康朗生物科技有限公司
    2025年07月12日询价
    ¥800
    上海沪震实业有限公司
    2025年07月16日询价
    ¥2200
    上海钰博生物科技有限公司
    2025年07月10日询价
    SW48
    询价